98%
921
2 minutes
20
Purpose: To report the efficacy and safety of navigated 577nm yellow subthreshold micropulse laser (YSML) treatment in a case of refractory cystoid macular edema (CME) following combined phaco-vitrectomy for rhegmatogenous retinal detachment (RRD).
Observations: A 69-year-old male patient complained a slow and progressive visual loss in the right eye (RE) since two months. A complete ophthalmological evaluation was performed. Best corrected visual acuity (BCVA) was hand motion and slit lamp examination revealed a nuclear cataract and a total macula-off RRD in the RE. Patient underwent a combined phaco +25 gauge pars plana vitrectomy (PPV) with 5000 cSt silicon oil (SO) tamponade. At the 3-month follow up BCVA was 20/250, retina was completely flat but a macular proliferative vitreoretinopathy (PVR) was detected with swept source optical coherence tomography (SS-OCT) and a second 23 G PPV with PVR peeling and SO removal was performed. At 1 month visit from the second surgery retina was flat and BCVA was 20/200 due to a persistent CME. Oral carbonic anhydrase inhibitors and topical steroids were administered for 2 months without any improvements. At this point, YSML was applied with a macular grid pattern and at three months follow up visit SS-OCT showed a complete resolution of CME, BCVA was 20/100 and these anatomical and functional outcomes were maintained at 6 months follow-up.
Conclusions And Importance: YSML treatment may be considered a safe and effective treatment strategy for the management of refractory CME following complex RRD surgery cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809002 | PMC |
http://dx.doi.org/10.1016/j.ajoc.2023.101981 | DOI Listing |
To report the results of Endpoint Management (EpM) with PASCAL laser in the treatment of chronic central serous retinopathy (CSR). A 577 nm yellow laser was applied using PASCAL with EpM to 11 eyes on 11 patients who were followed for CSR for at least 12 months in this prospective study. The laser spot size was set to 200 μm, the pulse duration was 15 msec, and the spot spacing was set to 0.
View Article and Find Full Text PDFJ Fr Ophtalmol
May 2025
Department of Ophthalmology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Basaksehir Olympic Boulevard Road, Basaksehir, Istanbul, Turkey.
Purpose: To evaluate the efficacy of navigated subthreshold micropulse laser (NSML) compared to subthreshold micropulse laser (SML) without navigation in the management of chronic central serous chorioretinopathy (CSCR).
Materials And Methods: This retrospective study included patients diagnosed with chronic CSCR who underwent either NSML or SML without navigation. Patients meeting inclusion criteria presented with serous macular detachment and leakage at the level of the retinal pigment epithelium on fundus fluorescein angiography (FFA).
Front Med (Lausanne)
November 2024
Shenzhen Eye Hospital, Shenzhen Eye Institute, Shenzhen Eye Hospital Affiliated to Jinan University, Shenzhen, China.
Purpose: To assess the safe, lowest effective laser power of subthreshold micropulse laser (SML) for treating acute and chronic central serous chorioretinopathy (CSC) in Chinese patients.
Methods: Patients were distinguished with acute or chronic CSC based on focal or diffuse retinal pigment epithelium (RPE) leakage on fundus fluorescein angiography (FFA), with or without widespread RPE decompensation. Patients were categorized into five groups and treated with 577 nm yellow SML according to 50% titration power.
Eur J Ophthalmol
November 2024
Ophthalmology Unit, University Hospital of Parma, Parma, Italy.
Purpose: To assess the safety and efficacy of the yellow sub-threshold micropulse laser (YSML) in eyes with uveitic macula edema (UME).
Methods: A prospective interventional study. Eyes with non-infectious UME and an unsatisfactory response to prior conventional treatments underwent navigated YSML (NAVILAS).
Sci Rep
September 2024
Chongqing Aier Eye Hospital, No.2 Huatang Road, Chongqing, China.